Koers Medicine Man Technologies Inc OTC Bulletin Board
Aandelen
US58468U1060
Farmaceutische producten
Omzet 2024 * | 174 mln. 163 mln. | Omzet 2025 * | 192 mln. 180 mln. | Marktkapitalisatie | 58,77 mln. 55,09 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 0,34 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,31 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 77,84% |
Recentste transcriptie over Medicine Man Technologies Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 16-01-23 | |
Justin Dye
CHM | Chairman | 52 | 05-06-19 |
Ed Eissenstat
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kathy Vrabeck
BRD | Director/Board Member | 60 | 02/11 |
Jeffrey Cozad
BRD | Director/Board Member | 60 | 15-03-21 |
Marc Rubin
BRD | Director/Board Member | 50 | 28-10-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,33% | 6,11 mld. | |
-18,38% | 4,35 mld. | |
-9,17% | 3,18 mld. | |
+3,98% | 3,16 mld. | |
-3,41% | 2,51 mld. | |
+48,74% | 1,98 mld. | |
-4,82% | 1,74 mld. | |
-1,24% | 1,63 mld. | |
-8,96% | 1,6 mld. |